JC CEROTTINI's scientific contributions

What is this page?
This page lists the scientific contributions of an author, who either does not have a ResearchGate profile, or has not yet added these contributions to their profile.

It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.

If you're a ResearchGate member, you can follow this page to keep up with this author's work.

If you are this author, and you don't want us to display this page anymore, please let us know.

Publication (1)

TUMOR-ANTIGENS RECOGNIZED BY T-LYMPHOCYTES
Article
  • Jan 1994
Transplantation experiments have demonstrated that most mouse tumors express antigens that can constitute targets for rejection responses mediated by syngeneic T lymphocytes. For human tumors, autologous cultures mixing tumor cells and blood lymphocytes or tumor-infiltrating lymphocytes have produced CD8(+) and CD4(+) cytolytic T cell (CTL) clones...
Cite
Request full-text

Citations

... The collection and sequencing of the peptides exhibited by MHC class I molecules at the cell surface is a technique to discover antigens [127]. Copyright 2019, with permission from ACS recognized by CTL on the majority of HLA-A*02 melanomas, even though this is often employed to identify genes rather than peptides [123]. Predicted binding to MHC class I and the structural stability of the interacting peptide-MHC class I complex have both been used to identify peptide epitopes that promote tumor immunogenicity [124]. ...
Reference: Peptide-Based Therapeutics in Cancer Therapy
View